-
1دورية أكاديمية
المساهمون: Byoung Chul Cho, Enriqueta Felip, Hidetoshi Hayashi, Michael Thomas, Shun Lu, Benjamin Besse, Tao Sun, Melissa Martinez, Seema N Sethi, S Martin Shreeve, Alexander I Spira, Cho, Byoung Chul
مصطلحات موضوعية: Acrylamides / adverse effects, Acrylamides / therapeutic use, Adolescent, Adult, Aniline Compounds / adverse effects, Aniline Compounds / therapeutic use, Antibodies, Bispecific / adverse effects, Bispecific / therapeutic use, Antineoplastic Agents, Immunological / adverse effects, Immunological / therapeutic use, Antineoplastic Combined Chemotherapy Protocols / adverse effects, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, Carcinoma, Non-Small-Cell Lung / drug therapy, Non-Small-Cell Lung / genetics, Non-Small-Cell Lung / pathology, ErbB Receptors / antagonists & inhibitors, ErbB Receptors / genetics, Humans, Lung Neoplasms / drug therapy, Lung Neoplasms / genetics, Lung Neoplasms / pathology, Morpholines / adverse effects, Morpholines / therapeutic use, Mutation, Neoplasm Metastasis, Protein Kinase Inhibitors / adverse effects, Protein Kinase Inhibitors / therapeutic use
العلاقة: FUTURE ONCOLOGY; J00914; OAK-2022-05607; https://ir.ymlib.yonsei.ac.kr/handle/22282913/191236Test; T202205272; FUTURE ONCOLOGY, Vol.18(6) : 639-647, 2022-02
الإتاحة: https://doi.org/10.2217/fon-2021-0923Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/191236Test -
2دورية أكاديمية
المساهمون: Justin F Gainor, Giuseppe Curigliano, Dong-Wan Kim, Dae Ho Lee, Benjamin Besse, Christina S Baik, Robert C Doebele, Philippe A Cassier, Gilberto Lopes, Daniel S W Tan, Elena Garralda, Luis G Paz-Ares, Byoung Chul Cho, Shirish M Gadgeel, Michael Thomas, Stephen V Liu, Matthew H Taylor, Aaron S Mansfield, Viola W Zhu, Corinne Clifford, Hui Zhang, Michael Palmer, Jennifer Green, Christopher D Turner, Vivek Subbiah, Cho, Byoung Chul
مصطلحات موضوعية: Aged, Antineoplastic Agents / adverse effects, Antineoplastic Agents / therapeutic use, Biomarkers, Tumor / genetics, Carcinoma, Non-Small-Cell Lung / drug therapy, Non-Small-Cell Lung / genetics, Non-Small-Cell Lung / pathology, Female, Gene Fusion, Humans, Lung Neoplasms / drug therapy, Lung Neoplasms / genetics, Lung Neoplasms / pathology, Male, Middle Aged, Protein Kinase Inhibitors / adverse effects, Protein Kinase Inhibitors / therapeutic use, Proto-Oncogene Proteins c-ret / antagonists & inhibitors, Proto-Oncogene Proteins c-ret / genetics, Pyrazoles / adverse effects, Pyrazoles / therapeutic use, Pyridines / adverse effects, Pyridines / therapeutic use, Pyrimidines / adverse effects, Pyrimidines / therapeutic use, Time Factors, Treatment Outcome
العلاقة: LANCET ONCOLOGY; J02154; OAK-2021-05094; https://ir.ymlib.yonsei.ac.kr/handle/22282913/184725Test; https://www.sciencedirect.com/science/article/pii/S1470204521002473Test; T202103493; LANCET ONCOLOGY, Vol.22(7) : 959-969, 2021-07
الإتاحة: https://doi.org/10.1016/S1470-2045Test(21)00247-3
https://ir.ymlib.yonsei.ac.kr/handle/22282913/184725Test
https://www.sciencedirect.com/science/article/pii/S1470204521002473Test -
3دورية أكاديمية
المساهمون: Robert C Doebele, Alexander Drilon, Luis Paz-Ares, Salvatore Siena, Alice T Shaw, Anna F Farago, Collin M Blakely, Takashi Seto, Byung Chul Cho, Diego Tosi, Benjamin Besse, Sant P Chawla, Lyudmila Bazhenova, John C Krauss, Young Kwang Chae, Minal Barve, Ignacio Garrido-Laguna, Stephen V Liu, Paul Conkling, Thomas John, Marwan Fakih, Darren Sigal, Herbert H Loong, Gary L Buchschacher Jr, Pilar Garrido, Jorge Nieva, Conor Steuer, Tobias R Overbeck, Daniel W Bowles, Elizabeth Fox, Todd Riehl, Edna Chow-Maneval, Brian Simmons, Na Cui, Ann Johnson, Susan Eng, Timothy R Wilson, George D Demetri, Cho, Byoung Chul
مصطلحات موضوعية: Aged, Antineoplastic Agents / adverse effects, Antineoplastic Agents / therapeutic use, Benzamides / adverse effects, Benzamides / therapeutic use, Biomarkers, Tumor / genetics, Clinical Trials, Phase I as Topic, Phase II as Topic, Female, Gene Fusion, Humans, Indazoles / adverse effects, Indazoles / therapeutic use, Male, Membrane Glycoproteins / antagonists & inhibitors, Membrane Glycoproteins / genetics, Middle Aged, Neoplasm Metastasis, Neoplasms / drug therapy, Neoplasms / genetics, Neoplasms / mortality, Neoplasms / pathology, Protein Kinase Inhibitors / adverse effects, Protein Kinase Inhibitors / therapeutic use, Receptor, trkA / antagonists & inhibitors, trkA / genetics, trkB / antagonists & inhibitors
العلاقة: LANCET ONCOLOGY; J02154; OAK-2022-03936; https://ir.ymlib.yonsei.ac.kr/handle/22282913/190243Test; T9992020468; LANCET ONCOLOGY, Vol.21(2) : 271-282, 2020-02
الإتاحة: https://doi.org/10.1016/S1470-2045Test(19)30691-6
https://ir.ymlib.yonsei.ac.kr/handle/22282913/190243Test -
4دورية أكاديمية
المساهمون: Oliver Gautschi, Julie Milia, Thomas Filleron, Juergen Wolf, David P Carbone, Dwight Owen, Ross Camidge, Vignhesh Narayanan, Robert C Doebele, Benjamin Besse, Jordi Remon-Masip, Pasi A Janne, Mark M Awad, Nir Peled, Chul-Cho Byoung, Daniel D Karp, Michael Van Den Heuvel, Heather A Wakelee, Joel W Neal, Tony S K Mok, James C H Yang, Sai-Hong Ignatius Ou, Georg Pall, Patrizia Froesch, Gérard Zalcman, David R Gandara, Jonathan W Riess, Vamsidhar Velcheti, Kristin Zeidler, Joachim Diebold, Martin Früh, Sebastian Michels, Isabelle Monnet, Sanjay Popat, Rafael Rosell, Niki Karachaliou, Sacha I Rothschild, Jin-Yuan Shih, Arne Warth, Thomas Muley, Florian Cabillic, Julien Mazières, Alexander Drilon, Cho, Byoung Chul
مصطلحات موضوعية: Adult, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, Carcinoma, Non-Small-Cell Lung / drug therapy, Non-Small-Cell Lung / enzymology, Non-Small-Cell Lung / epidemiology, Non-Small-Cell Lung / genetics, Gene Rearrangement, Humans, International Cooperation, Lung Neoplasms / drug therapy, Lung Neoplasms / enzymology, Lung Neoplasms / epidemiology, Lung Neoplasms / genetics, Middle Aged, Molecular Targeted Therapy, Prospective Studies, Protein Kinase Inhibitors / therapeutic use, Proto-Oncogene Proteins c-ret / antagonists & inhibitors, Proto-Oncogene Proteins c-ret / genetics, Registries, Treatment Outcome
العلاقة: JOURNAL OF CLINICAL ONCOLOGY; J01331; OAK-2017-1186; https://ir.ymlib.yonsei.ac.kr/handle/22282913/195754Test; T992017278; JOURNAL OF CLINICAL ONCOLOGY, Vol.35(13) : 1403-1410, 2017-05
الإتاحة: https://doi.org/10.1200/JCO.2016.70.9352Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/195754Test